Incidence of postoperative complications in breast cancer patients depending on their tumor subtype and type of surgery

Background. Breast cancer is distinguished by its heterogeneity. The biological subtype of the tumor influences the choice of treatment tactics, components of complex therapy. The appearance of targeted drugs made it possible to expand the indications of reconstructive plastic surgery in patients wi...

Full description

Saved in:
Bibliographic Details
Main Authors: A. Kh. Ismagilov, V. E. Karasev, D. M. Vyushkov
Format: Article
Language:Russian
Published: ABV-press 2023-08-01
Series:Опухоли женской репродуктивной системы
Subjects:
Online Access:https://ojrs.abvpress.ru/ojrs/article/view/1103
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849399279363293184
author A. Kh. Ismagilov
V. E. Karasev
D. M. Vyushkov
author_facet A. Kh. Ismagilov
V. E. Karasev
D. M. Vyushkov
author_sort A. Kh. Ismagilov
collection DOAJ
description Background. Breast cancer is distinguished by its heterogeneity. The biological subtype of the tumor influences the choice of treatment tactics, components of complex therapy. The appearance of targeted drugs made it possible to expand the indications of reconstructive plastic surgery in patients with breast cancer.Aim. To study the influence of the biological subtype of breast tumor on the frequency of complications after simultaneous and delayed reconstructive plastic surgeries.Materials and methods. The postoperative period of 577 patients 18–40 years with a diagnosis of stage I–IIIA unilateral breast cancer was studied. In 61.2 %, luminal cancer, subtype A, was verified, in 6.1 % – luminal cancer, subtype B, in 10.4 % – HER2-positive (luminal) ER+PR+, in 7.3 % – HER2-positive (non-luminal) ER–PR–, in 15 % – three times negative. All patients underwent surgical treatment, including, taking into account the indications and contraindications, in the volume of Madden mastectomy – 43.5 %, mastectomy with simultaneous two-stage reconstruction with silicone implants – 34.8 %, mastectomy with delayed two-stage reconstruction with silicone implants – 21.7 %.Results. In most patients, the early postoperative period was favorable, complications were recorded in 11.8 %: in 11.3 % of patients of group I, 11.4 % of group II, 11.7 % of group III, 14.3 % of group IV, 12.6 % of group V. After radical mastectomy, complications were recorded in 13.5 % of cases, after mastectomy with simultaneous and delayed reconstruction – in 10.4 %. The treatment efficacy rate was 65.2–84.6 %. Late postoperative complications were recorded in group I in 24.1 % of patients, in group II – in 22.9 %, in group III – in 23.3 %, in group IV – in 26.2 %, in group V – in 24.1 %. Among patients who underwent only radical mastectomy, complications were noted in 24.7 %, mastectomy with simultaneous reconstruction – in 24.9 %, mastectomy with delayed reconstruction – in 21.6 %. The treatment efficacy rate was 42.9–59.5 %.Conclusion. Our study did not reveal a relationship between the incidence of early and late postoperative complications in patients with different biological tumor types. Based on the literature, it can be assumed that not the type of tumor, but individually prescribed systemic therapy makes a significant contribution to the development of postoperative complications, which should be taken into account when planning reconstructive plastic surgeries.
format Article
id doaj-art-18e8bfccdee34af09778336b2afcf92c
institution Kabale University
issn 1994-4098
1999-8627
language Russian
publishDate 2023-08-01
publisher ABV-press
record_format Article
series Опухоли женской репродуктивной системы
spelling doaj-art-18e8bfccdee34af09778336b2afcf92c2025-08-20T03:38:23ZrusABV-pressОпухоли женской репродуктивной системы1994-40981999-86272023-08-01192616810.17650/1994-4098-2023-19-2-61-68799Incidence of postoperative complications in breast cancer patients depending on their tumor subtype and type of surgeryA. Kh. Ismagilov0V. E. Karasev1D. M. Vyushkov2Kazan State Medical Academy, Ministry of Health of RussiaOmsk State Medical University; Clinical Oncology DispensaryClinical Oncology DispensaryBackground. Breast cancer is distinguished by its heterogeneity. The biological subtype of the tumor influences the choice of treatment tactics, components of complex therapy. The appearance of targeted drugs made it possible to expand the indications of reconstructive plastic surgery in patients with breast cancer.Aim. To study the influence of the biological subtype of breast tumor on the frequency of complications after simultaneous and delayed reconstructive plastic surgeries.Materials and methods. The postoperative period of 577 patients 18–40 years with a diagnosis of stage I–IIIA unilateral breast cancer was studied. In 61.2 %, luminal cancer, subtype A, was verified, in 6.1 % – luminal cancer, subtype B, in 10.4 % – HER2-positive (luminal) ER+PR+, in 7.3 % – HER2-positive (non-luminal) ER–PR–, in 15 % – three times negative. All patients underwent surgical treatment, including, taking into account the indications and contraindications, in the volume of Madden mastectomy – 43.5 %, mastectomy with simultaneous two-stage reconstruction with silicone implants – 34.8 %, mastectomy with delayed two-stage reconstruction with silicone implants – 21.7 %.Results. In most patients, the early postoperative period was favorable, complications were recorded in 11.8 %: in 11.3 % of patients of group I, 11.4 % of group II, 11.7 % of group III, 14.3 % of group IV, 12.6 % of group V. After radical mastectomy, complications were recorded in 13.5 % of cases, after mastectomy with simultaneous and delayed reconstruction – in 10.4 %. The treatment efficacy rate was 65.2–84.6 %. Late postoperative complications were recorded in group I in 24.1 % of patients, in group II – in 22.9 %, in group III – in 23.3 %, in group IV – in 26.2 %, in group V – in 24.1 %. Among patients who underwent only radical mastectomy, complications were noted in 24.7 %, mastectomy with simultaneous reconstruction – in 24.9 %, mastectomy with delayed reconstruction – in 21.6 %. The treatment efficacy rate was 42.9–59.5 %.Conclusion. Our study did not reveal a relationship between the incidence of early and late postoperative complications in patients with different biological tumor types. Based on the literature, it can be assumed that not the type of tumor, but individually prescribed systemic therapy makes a significant contribution to the development of postoperative complications, which should be taken into account when planning reconstructive plastic surgeries.https://ojrs.abvpress.ru/ojrs/article/view/1103biological subtype of tumorpostoperative complicationsbreast cancerreconstructive plastic surgery
spellingShingle A. Kh. Ismagilov
V. E. Karasev
D. M. Vyushkov
Incidence of postoperative complications in breast cancer patients depending on their tumor subtype and type of surgery
Опухоли женской репродуктивной системы
biological subtype of tumor
postoperative complications
breast cancer
reconstructive plastic surgery
title Incidence of postoperative complications in breast cancer patients depending on their tumor subtype and type of surgery
title_full Incidence of postoperative complications in breast cancer patients depending on their tumor subtype and type of surgery
title_fullStr Incidence of postoperative complications in breast cancer patients depending on their tumor subtype and type of surgery
title_full_unstemmed Incidence of postoperative complications in breast cancer patients depending on their tumor subtype and type of surgery
title_short Incidence of postoperative complications in breast cancer patients depending on their tumor subtype and type of surgery
title_sort incidence of postoperative complications in breast cancer patients depending on their tumor subtype and type of surgery
topic biological subtype of tumor
postoperative complications
breast cancer
reconstructive plastic surgery
url https://ojrs.abvpress.ru/ojrs/article/view/1103
work_keys_str_mv AT akhismagilov incidenceofpostoperativecomplicationsinbreastcancerpatientsdependingontheirtumorsubtypeandtypeofsurgery
AT vekarasev incidenceofpostoperativecomplicationsinbreastcancerpatientsdependingontheirtumorsubtypeandtypeofsurgery
AT dmvyushkov incidenceofpostoperativecomplicationsinbreastcancerpatientsdependingontheirtumorsubtypeandtypeofsurgery